Haleos Labs appoints Suryanarayana & Suresh as statutory auditors for 5-year term

1 min read     Updated on 30 May 2026, 03:38 AM
scanx
Reviewed by
Anirudha BScanX News Team
AI Summary

Haleos Labs Limited has appointed Suryanarayana & Suresh as statutory auditors for a five-year term starting from the conclusion of the 20th Annual General Meeting, replacing M/s Rambabu & Co. Additionally, the Board reappointed Annapragada & Co. as Cost Auditors for the financial year 2026-27. Both appointments are subject to shareholder approval.

powered bylight_fuzz_icon
41015293

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has appointed Suryanarayana & Suresh, Chartered Accountants, as its statutory auditors for a period of five years, subject to shareholder approval. The Board of Directors approved the appointment at its meeting held on May 29, 2026, based on the recommendation of the Audit Committee. The new auditors will serve from the conclusion of the 20th Annual General Meeting until the conclusion of the 25th Annual General Meeting. This decision follows the completion of the second term of the existing statutory auditors, M/s Rambabu & Co., necessitating the identification of a new firm in accordance with Section 139 of the Companies Act, 2013.

Statutory Auditor Appointment

The Board appointed Suryanarayana & Suresh (Firm Registration No. 006631S) to replace the outgoing auditors. The firm, established in 1994 and headquartered in Hyderabad, brings over three decades of experience in audit & assurance, taxation, and regulatory compliance. The appointment is pending approval by the shareholders.

Cost Auditor Reappointment

In addition to the statutory auditor change, the Board approved the reappointment of Annapragada & Co. as Cost Auditors for the financial year 2026-27. The firm, formerly known as Harshitha Annapragada & Co., was reappointed pursuant to Section 148 of the Companies Act, 2013, and the Companies (Audit and Auditors) Rules, 2014. The remuneration for the cost auditors is also subject to shareholder approval.

The table below summarises the auditor appointments:

Auditor Type Firm Name Term / Period Status
Statutory Auditor Suryanarayana & Suresh 5 years (20th AGM to 25th AGM) Subject to Shareholder Approval
Cost Auditor Annapragada & Co. FY 2026-27 Subject to Shareholder Approval

Regulatory Disclosures

The company disclosed that there are no relationships between the newly appointed auditors and the directors of Haleos Labs Limited. The filings were made to BSE Limited and the National Stock Exchange of India Limited in compliance with Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
+1.96%+3.43%-7.43%+11.66%+26.08%+131.46%

How will the transition from M/s Rambabu & Co. to Suryanarayana & Suresh impact Haleos Labs' audit processes and financial reporting timelines?

What factors influenced the Board's decision to select Suryanarayana & Suresh over other potential audit firms?

How might shareholders respond to the proposed auditor appointments during the upcoming Annual General Meeting?

Haleos Labs Postal Ballot Result: Shareholders Approve Corporate Guarantee with 99.99% Votes

2 min read     Updated on 02 May 2026, 09:55 PM
scanx
Reviewed by
Jubin VScanX News Team
AI Summary

Haleos Labs Limited successfully concluded its postal ballot process with shareholders overwhelmingly approving the Material Related Party Transaction involving corporate guarantee to RBL Bank. The resolution received 1,05,592 votes in favour out of 1,05,600 total votes polled, representing 99.9924% approval rate. The transaction secures External Corporate Borrowings facility for subsidiary Mahi Drugs Private Limited, demonstrating strong shareholder confidence in the company's strategic decisions.

powered bylight_fuzz_icon
39138758

*this image is generated using AI for illustrative purposes only.

Haleos Labs Limited has successfully concluded its postal ballot process for seeking shareholder approval on Material Related Party Transactions involving the issuance of a corporate guarantee to RBL Bank. The resolution was passed on April 29, 2026, securing the External Corporate Borrowings facility availed by Mahi Drugs Private Limited, a subsidiary of the company.

Overwhelming Shareholder Support

The postal ballot results demonstrated exceptional shareholder confidence in the proposed transaction. The voting process was conducted exclusively through e-voting from March 31, 2026, to April 29, 2026, with Mr. C. Sudhir Babu of CSB Associates serving as the scrutinizer.

Voting Results: Details
Total Votes Polled: 1,05,600
Votes in Favour: 1,05,592 (99.9924%)
Votes Against: 8 (0.0076%)
Outstanding Shares Representation: 3.4929%

Category-wise Voting Breakdown

The detailed voting analysis reveals strong support across all shareholder categories. Public institutions showed unanimous support, while public non-institutions demonstrated near-complete approval for the resolution.

Category: Shares Held Votes Polled Votes in Favour Votes Against % in Favour
Promoter and Promoter Group: 21,79,976 - - - -
Public – Institutions: 8,932 8,932 8,932 - 100.0000%
Public – Non-Institutions: 8,34,379 96,668 96,660 8 99.9917%
Grand Total: 30,23,287 1,05,600 1,05,592 8 99.9924%

Resolution and Transaction Details

The Ordinary Resolution sought approval for the issuance of a corporate guarantee in favour of RBL Bank to secure the External Corporate Borrowings facility availed by Mahi Drugs Private Limited. Members holding equity shares as of the cut-off date of March 27, 2026, were entitled to vote on the proposed resolution. The Promoter and Promoter Group were interested parties in this agenda resolution.

Scrutinizer's Confirmation

Mr. C. Sudhir Babu, Practicing Company Secretary from CSB Associates, confirmed that the e-voting process was conducted in a fair and transparent manner. The company appointed Central Depository Services Limited (CDSL) as the agency for providing the e-voting facility. According to the scrutinizer's report, 68 members voted in favour while 3 members voted against the resolution, with no invalid votes recorded during the process.

Regulatory Compliance

The company has fulfilled all regulatory requirements under Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The results have been uploaded on the company's website at www.haleoslabs.com and on Central Depository Services (India) Limited's website at www.cdslindia.com . The scrutinizer's report has been submitted to the Managing Director, and all relevant records relating to e-voting will remain in safe custody until the minutes are signed and approved.

Historical Stock Returns for Haleos

1 Day5 Days1 Month6 Months1 Year5 Years
+1.96%+3.43%-7.43%+11.66%+26.08%+131.46%

What specific expansion or operational initiatives will Mahi Drugs Private Limited pursue with the RBL Bank borrowing facility?

How might this corporate guarantee arrangement affect Haleos Labs' debt capacity and credit rating in future financing decisions?

Will Haleos Labs consider similar guarantee structures for other subsidiaries to support their growth strategies?

More News on Haleos

1 Year Returns:+26.08%